According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$7.5 M. In 2023 the company made an earning of -NZ$7.18 M an increase over its 2022 earnings that were of -NZ$10.48 M.The earnings displayed on this page is the company's Pretax Income.